Page 6 - Surmodics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Shockwave Medical (NASDAQ:SWAV – Get Free Report) and Surmodics (NASDAQ:SRDX – Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, earnings, analyst recommendations, profitability and risk. Profitability This table compares Shockwave Medical and Surmodics’ net […]

Surmodics (NASDAQ:SRDX – Get Free Report) and Shockwave Medical (NASDAQ:SWAV – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, profitability, institutional ownership, earnings, risk and analyst recommendations. Risk and Volatility Surmodics has a beta of 1.05, […]

Coronavirus Immunoassay MarketThe global coronavirus immunoassay market size has exhibited remarkable growth, hitting a substantial mark of US$ 3.7 Billion in 2021. According to recent market analyses, this thriving sector is poised for further expansion, foreseeing a robust Compound Annual Growth Rate (CAGR) of 5.5...

Surmodics (NASDAQ:SRDX – Get Free Report) issued an update on its FY 2024 earnings guidance on Thursday morning. The company provided earnings per share guidance of -1.170–0.870 for the period, compared to the consensus earnings per share estimate of -1.160. The company issued revenue guidance of $113.0 million-$117.0 million, compared to the consensus revenue estimate […]

Key Insights Surmodics will host its Annual General Meeting on 8th of February Salary of US$640.4k is part of CEO Gary...